ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.405,92
-0,11%
S&P 500
6.051,09
0,00%
Dow Jones
43.828,06
-0,20%
Euro vs US Dollar
1,0502
-0,04%
Bitcoin
101.080,94
-0,37%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Nkarta Inc (NKTX)

  7. Nkarta Inc (NKTX) News

NKTX

Nkarta (NKTX)

Nkarta Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NKTX
DatumZeitQuelleÜberschriftSymbolFirma
05/12/202412h01GlobeNewswire Inc.Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2NASDAQ:NKTXNkarta Inc
26/11/202413h02GlobeNewswire Inc.Nkarta to Participate in an Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
14/11/202422h05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NKTXNkarta Inc
12/11/202414h02GlobeNewswire Inc.Nkarta to Participate in an Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
08/11/202420h17Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:NKTXNkarta Inc
07/11/202422h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NKTXNkarta Inc
07/11/202422h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
07/11/202422h02GlobeNewswire Inc.Nkarta Reports Third Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
26/10/202403h44Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NKTXNkarta Inc
26/10/202403h44Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NKTXNkarta Inc
03/09/202422h01GlobeNewswire Inc.Nkarta to Participate in Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
23/08/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
14/08/202403h03GlobeNewswire Inc.Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
13/08/202422h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NKTXNkarta Inc
13/08/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
13/08/202422h01GlobeNewswire Inc.Nkarta Reports Second Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
31/07/202422h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
31/07/202422h47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
31/07/202422h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
24/07/202412h00GlobeNewswire Inc.Nkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus ErythematosusNASDAQ:NKTXNkarta Inc
16/07/202412h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
16/07/202412h01GlobeNewswire Inc.Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as PresidentNASDAQ:NKTXNkarta Inc
27/06/202412h00GlobeNewswire Inc.Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune IndicationsNASDAQ:NKTXNkarta Inc
14/06/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
14/06/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
14/06/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
14/06/202422h04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
13/06/202422h22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
13/06/202422h01GlobeNewswire Inc.Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of DirectorsNASDAQ:NKTXNkarta Inc
09/05/202422h14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NKTXNkarta Inc
 Showing the most relevant articles for your search:NASDAQ:NKTX

Kürzlich von Ihnen besucht

AMEX
XLF
Financial Select Sector
FX
EURGBP
Euro vs Sterling
CCOM
US30
US 30
FX
EURUSD
Euro vs US Dollar
NYSE
NKE
Nike
PM
XAUUSD
Gold vs US Dollar
COIN
ETHUSD
Ethereum
TG
CBK
Commerzbank
NYSE
MRK
Merck
COIN
XRPUSD
Ripple
TG
BAS
BASF
CCOM
US100
US Tech 100
USOTC
BASFY
BASF (QX)
FX
EURJPY
Euro vs Yen
TG
432
Arbor Metals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten